all the latest information in graft-
arranged by experts and healthcare professionals. Listed below are recently added expert opinions.
How can we use the microbiome to improve cancer immunotherapy and alleviate side effect such as graft-versus-host-disease
Interview with Christine Spencer, Parker Institute of Cancer Immunotherapy,...
REACH2: What patients with steroid-refractory acute GvHD respond best to ruxolitinib?
An interview from the 25th Congress of the EHA with Robert Zeiser, Medical Center – University of Freiburg,...
What factors impact response to mesenchymal stromal cells in patients with acute GvHD?
During the 25th Congress of the EHA, the GvHD Hub spoke to Antonio Galleu, King's College London. We asked: What...
ALPHA study: First-in-human data of ALLO-501 and ALLO-647 in R/R large B-cell or follicular lymphoma
During the American Society of Clinical Oncology (ASCO) Annual Meeting, the GvHD Hub was pleased to...
Treatment of SR-GvHD and subsequent trial updates at EHA 2020
This year at EHA2020, we will be providing coverage of the oral presentations that provide updates on the trials focusing on novel...
Comparison of ruxolitinib with other therapies for steroid-refractory acute GvHD
A phase III study REACH2 comparing the efficacy and safety of ruxolitinib with nine commonly used therapies in patients...
Management of patients with steroid-refractory acute graft-versus-host disease – treatment options and unmet clinical need
A review evaluating both current and emerging treatment and management...
COVID-HEME forum supports hematologists during COVID-19 pandemic
Philippe Armand and Roch Houot share information related to the recently launched COVID-HEME initiative including how hematologists can...
H. Joachim Deeg
Jean El Cheikh
Kate A Markey
Marcel van den Brink